The European Medicines Agency (EMA) has issued a warning about a rare but serious risk linked to a popular treatment for men’s hair loss. The treatment, commonly used to address hair thinning, may increase the risk of suicidal thoughts in some individuals.
The treatment, known as finasteride, is commonly used to prevent hair loss and promote hair growth in men. It works by reducing the hormone responsible for hair thinning. However, the EMA’s new review highlights that the drug may carry a rare risk of mental health side effects.
While the treatment is effective for many men, the EMA reports that it has been linked to suicidal thoughts and other mood disorders in some cases. These side effects, although rare, have raised concerns about the mental health safety of those using the drug.
The EMA is urging healthcare providers to carefully monitor patients who are using finasteride for any signs of depression or suicidal thoughts. Patients are advised to seek medical advice immediately if they experience any changes in mood or behavior.
Although finasteride remains a widely used and effective treatment for hair loss, the potential for rare mental health side effects has prompted health regulators to issue a warning. Users should be aware of the risks and consult their healthcare providers for further guidance.
Related topics:
- The Ultimate Guide To Hair Growth Supplements For Men
- Top 6 Hair Growth Supplements for Men
- The Best 5 Hair Growth Supplements for Men
